Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Molecular Chaperones and Co-chaperones as Therapeutic Targets for Cancer
Atta Ahmad and Mahvish Muzaffar
Editorial: J Mol Pharm Org Process Res 2016, 4:e124
HER2-Targeted Antibody Treatment for Ovarian Cancer Future Opportunities
Simon P Langdon and Andrew H Sims
Editorial: J Mol Pharm Org Process Res 2016, 4:1
Formulation, Characterization and Pharmacokinetic Evaluation of Telmisartan Solid Dispersions
Arno A Enose, Priya Dasan, Hariharan Sivaramakrishanan and Vandita Kakkar
Research Article: J Mol Pharm Org Process Res 2016, 4:131
Alternatives to Animal Procedures in Drug Development
Letter to Editor: J Mol Pharm Org Process Res 2016, 4:132
Rethinking Demethylating Agents in Epigenetic Cancer Therapy
Fides D Lay and Gangning Liang
Letter to Editor: J Mol Pharm Org Process Res 2016, 4:133
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals